Omixon to Sponsor EWIC 2019 Conference with Scientific Talk

Omixon is proud to announce that we are one of the Silver Sponsors of the Annual EWIC 2019 Conference. Libor Kolesár (Senior Field Application Scientist) and Nina Lauterbach (Field Application Scientist) will announce improvements to the existing products and an interesting talk by Mette Christiansen from Aarhus University. Title of...

 

Read more

EWIC, March 14-16, 2019

We are happy to announce that Omixon is one of the Silver Sponsors of this year’s EWIC Conference in Zagreb, Croatia. Title of our talk: “Donor selection for solid organ transplantation guided by NGS high resolution HLA typing in combination with PIRCHE “ Date: Friday, March 15, 2019 Time:...

 

Read more

Automated NGS-based HLA Typing and Epitope Matching at the 44th ASHI Annual Meeting 2018

Omixon announce today that Holotype HLA and other Omixon products will be featured among nine posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium on Thursday 10/4 will focus on the importance...

 

Read more

Omixon & PIRCHE® collaborate on Epitope Determination with NGS

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...

 

Read more